NEUROPROTECTION IN SPINAL MUSCULAR ATROPHY (SMA) USING NEURAL STEM CELLS AS A THERAPEUTIC APPROACH

  • 3 Years 2009/2012
  • 257.900€ Total Award
The project objective is to contribute to the development of a stem cell therapy for Spinal Muscular Atrophy (SMA). SMA is a common motor neuron degeneration disorder, manifesting with progressive muscle weakness and paralysis and leading to death. It is caused by mutations in the survival motor neuron gene. We will investigate the therapeutic potential of transplanted neural stem cells generated from human adult reprogrammed somatic stem cells (induced pluripotent stem cells) to ameliorate the phenotype of an SMA mouse model. We will also use stem cells that are genetically modified to secrete growth factors and become more supportive to the motor neurons that die in SMA. The cells will be transplanted into the spinal cord of SMA mice, and we will evaluate whether and how their engraftment modifies disease progression. These experiments in the SMA mouse model explore the feasibility of stem cell therapy for SMA and other motor neuron diseases.

Scientific Publications

Il tuo browser non è più supportato da Microsoft, esegui l'upgrade a Microsoft Edge per visualizzare il sito.